MTI (9438) FY2026 Q3 Earnings Report

Quick View

Executive Summary

During the quarter, the Company secured revenue growth while recording a slight decline in operating income. However, ordinary income and net income increased, driven by a sharp expansion in equity-method investment gains, with the boost at the non-operating level supporting overall performance. Revenue was ¥232.8B (+4.4% year on year), operating income was ¥22.7B (-3.0%), ordinary income was ¥28.2B (+18.6%), and net income attributable to the period (consolidated) was ¥22.7B (+5.9%; of which net income attributable to owners of the parent was ¥21.75B, up +5.6%). The +10.0% increase in cost of sales exceeded revenue growth, causing the gross profit margin to decline to 73.1% from 74.5% in the previous year, which was the primary cause of the decline in operating income. Meanwhile, equity-method investment gains expanded from ¥0.6B to ¥5.5B, pushing up ordinary income.

Factors Behind Earnings Changes

【Revenue】Revenue was ¥232.8B, an increase of +4.4% year on year. By segment, SchoolDX increased +30.6%, Healthcare grew +19.3%, and Other rose +7.5%, while Content, the largest segment, recorded a revenue decline of -4.4%. Content accounted for 50.4% of total segment revenue (¥245.1B), and Company-wide growth was driven by the expansion of SchoolDX and Healthcare.

【Profit and Loss】Operating income was ¥22.7B, a decrease of -3.0% year on year. The primary factor was the +10.0% increase in cost of sales, which caused the gross profit margin to decline by 1.4pt from 74.5% to 73.1%; the SG&A ratio improved to 63.4% from 64.0% in the previous year, partially offsetting this impact. Ordinary income rose significantly to ¥28.2B (+18.6%), driven by the approximately ninefold increase in equity-method investment gains from ¥0.6B to ¥5.5B. Although the Company recorded an impairment loss on investment securities of ¥2.0B as a temporary factor under extraordinary losses, limiting profit before tax to ¥26.6B, net income attributable to the period (consolidated) reached ¥22.7B (+5.9%), partly due to the low effective tax rate of 14.6%. Revenue, ordinary income, and net income all increased, while only operating income declined; overall, the results are classified as higher revenue and higher earnings.

Segment Analysis

Despite lower revenue, Content maintained high profitability, with operating income up +10.6% and a margin of 27.2%, and remains the core contributor to Company-wide earnings. SchoolDX is expanding as a high-growth, high-profitability segment, with revenue up +30.6%, operating income up +66.9%, and a margin of 36.2%. Despite revenue growth of +19.3%, Healthcare’s operating result turned from a profit of ¥0.76B in the previous year to a loss of ¥5.66B. The combined operating income of the four segments reached ¥42.6B; however, after deducting Company-wide expenses not allocated to individual segments (approximately ¥19.9B), consolidated operating income was ¥22.7B. The structure in which Company-wide expenses weigh on the earnings mix therefore remains in place.

Key Financial Indicators

【Profitability】The operating margin was 9.8%, down -0.7pt from 10.5% in the previous year, primarily due to the decline in the gross profit margin caused by the increase in cost of sales (73.1%, compared with 74.5% in the previous year). The net profit margin based on consolidated net income attributable to the period was 9.7%, improving slightly by +0.1pt from 9.6% in the previous year, as the increase in equity-method investment gains offset the decline at the operating level.【Cash Flow Quality】Contract liabilities increased to ¥33.9B (+24.4% year on year), confirming the accumulation of deferred revenue, while accounts receivable remained broadly flat at ¥40.9B.【Investment Efficiency】Total asset turnover was approximately 0.70x, and ROE was 9.8%. Net assets were ¥231.9B against total assets of ¥334.5B, maintaining a high equity ratio of 69.3%.【Financial Soundness】The current ratio was 280% (current assets of ¥220.5B/current liabilities of ¥78.7B), while long-term borrowings decreased to ¥4.0B from ¥9.6B in the previous year, a decline of -57.8%, further reducing dependence on interest-bearing debt. Cash and deposits remained ample at ¥161.2B.

Cash Flow Analysis

Although a standalone cash flow statement has not been disclosed, funding trends can be assessed from changes in the balance sheet. Cash and deposits were ¥161.2B, down -9.5% from ¥178.2B in the previous year. Repayment of long-term borrowings (-¥5.5B, -57.8%), increases in investment securities (+¥6.5B, +13.8%), and higher investment in property, plant and equipment (+¥2.3B) were sources of cash outflow. Meanwhile, contract liabilities increased to ¥33.9B (+24.4%), and the accumulation of deferred revenue contributed positively from a working capital perspective. Accounts receivable remained broadly flat, with no sharp deterioration in collections. Net assets expanded to ¥231.9B, primarily due to a +¥10.7B (+11.9%) increase in retained earnings, indicating continued accumulation of equity through retained earnings.

Quality of Earnings

While operating income, which indicates recurring earnings power, was ¥22.7B, down -3.0% year on year, ordinary income expanded to ¥28.2B (+18.6%) due to the increase in equity-method investment gains (¥0.6B → ¥5.5B). Attention should be paid to the fact that the higher dependence on equity-method income, which has a high degree of non-recurring volatility, contributed to the increase in ordinary income. Under extraordinary gains and losses, the Company recorded an impairment loss on investment securities of ¥2.0B as a temporary factor and recognized extraordinary income of ¥0.4B, including gains on the sale of shares in subsidiaries. As a result, profit before tax was limited to ¥26.6B. The effective tax rate remained relatively low at 14.6%, calculated as corporate income taxes of ¥3.9B divided by profit before tax of ¥26.6B, supporting consolidated net income attributable to the period of ¥22.7B, including ¥21.75B attributable to owners of the parent. Comprehensive income was ¥23.8B, including ¥22.9B attributable to owners of the parent. The difference from net income was mainly attributable to foreign currency translation adjustments of +¥0.6B and the share of OCI of equity-method affiliates of +¥0.7B, with the divergence remaining limited. The increase in contract liabilities (+24.4%) indicates the accumulation of deferred revenue from an accrual perspective and can be viewed as a factor supporting the conversion of earnings into cash.

Earnings Forecast and Guidance

Progress against the full-year plan was 73.9% for revenue (¥232.8B/¥315.0B), 84.2% for operating income (¥22.7B/¥27.0B), 90.9% for ordinary income (¥28.2B/¥31.0B), and 81.2% for net income attributable to owners of the parent (¥21.75B/¥26.8B). While revenue has progressed broadly in line with the plan, earnings—particularly ordinary income—are progressing at a pace above plan, apparently supported by the increase in equity-method investment gains. The Company revised its earnings forecast during the quarter, but did not revise its dividend forecast. The full-year plan calls for operating income to decline -8.4% year on year, while ordinary income is expected to increase +2.4%.

Shareholder Returns

The interim dividend remains ¥10, and the full-year forecast, including the year-end dividend, remains ¥20, with no revision to the dividend forecast during the quarter. Based on the forecast of net income attributable to owners of the parent of ¥2.68B and forecast EPS of ¥48.25, the payout ratio is approximately 41.4% (¥20/¥48.25). Given the financial structure of cash and deposits of ¥161.2B and long-term borrowings of ¥4.0B, dividend funding is supported by cash on hand in addition to the operating base. No share repurchase has been disclosed.

Risk Factors

1. Segment concentration risk: Content accounts for 50.4% of total segment revenue (¥245.1B) and is also the leading segment in terms of operating income. Revenue from this business declined -4.4% year on year, and its high dependence on content and platform trends represents a risk factor in the earnings structure.

2. Deterioration in Healthcare’s profit and loss: Healthcare’s operating result turned from a profit of ¥0.76B in the previous year to a loss of ¥5.66B in the current period, a YoY change of -848.0%. Revenue increased +19.3%, apparently due to front-loaded investment, but the progress of monetization requires monitoring.

3. Dependence on highly non-recurring income: The increase in ordinary income (+18.6%) relies heavily on the sharp expansion in equity-method investment gains (¥0.6B → ¥5.5B). Together with the valuation fluctuation risk associated with investment securities of ¥53.4B (16.0% of total assets), this is a factor increasing earnings volatility.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

Both the Company’s operating margin and net profit margin exceed the industry median, placing its profitability relatively high within the industry.

Growth and Capital Efficiency

The revenue growth rate is below the industry median, indicating that the Company is somewhat behind its industry peers in terms of growth.

※Source: Compiled by the Company

Key Points from the Financial Results

1. The gross profit margin declined to 73.1% from 74.5% in the previous year, and rising costs pushed down the operating margin (-0.7pt). Meanwhile, the SG&A ratio improved to 63.4% from 64.0% in the previous year, indicating that the cost structure reflects a tug-of-war between cost pressures and SG&A efficiency improvements.

2. With Healthcare turning to an operating loss, the Company-wide earnings mix has become even more dependent on the highly profitable Content and SchoolDX segments. SchoolDX is achieving both high growth and high profitability, with operating income up +66.9% and a margin of 36.2%, strengthening its position as the next earnings driver.

3. Contract liabilities increased to ¥33.9B (+24.4%), indicating a deeper recurring revenue base accompanied by deferred revenue. Together with the increased dependence on equity-method investment gains, this underscores the importance of continuously monitoring changes in the earnings mix.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type, with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥433–¥458 for cost of equity ±1%, and ¥445–¥446 for ω±0.1.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model / Interest rate reference month: 2026-07 / This value does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

MTI delivered a solid FY2026 Q3 cumulative revenue performance, although operating-profit conversion weakened modestly. Revenue increased 4.4% year on year to ¥23.28bn. Operating income declined 3.0% to ¥2.27bn, reducing the operating margin to 9.8% from 10.5% in the prior-year period, a 70bp contraction. Gross profit rose to ¥17.02bn, but the gross margin fell 140bp to 73.1% as cost of sales grew faster than revenue. SG&A increased 3.3% to ¥14.75bn, broadly below sales growth, but the lower gross margin more than offset this discipline. Ordinary income nevertheless rose 18.6% to ¥2.82bn, supported by ¥0.55bn of equity-method earnings from affiliates, compared with ¥0.06bn a year earlier. Profit attributable to owners increased 5.6% to ¥2.18bn, and basic EPS rose to ¥39.20. The net margin improved slightly by approximately 10bp to 9.3%, despite the operating-margin decline. The effective tax rate was low at 14.6%, lifting the conversion of pre-tax profit into net income. Profit before tax declined 16.5% to ¥2.66bn because the prior-year period included substantially larger extraordinary income, while the current period recorded a net extraordinary loss of ¥0.16bn. Therefore, the year-on-year rise in net income was supported more by affiliate earnings and tax effects than by core operating-profit expansion. The balance sheet remains highly liquid, with cash and deposits of ¥16.12bn and a current ratio of 280.0%. Leverage is limited, with debt/capital of 1.7% and interest coverage of 162.6x. Full-year guidance implies Q3 progress of 73.9% for sales, 84.2% for operating income, 90.9% for ordinary income, and 81.2% for profit attributable to owners. The earnings trajectory indicates that management expects a softer fourth quarter, particularly in ordinary income after unusually strong affiliate-income contribution through Q3. The key issue for the remainder of FY2026 is whether expansion in Healthcare and School DX can sustainably offset the revenue decline in the core Content business while restoring gross-margin and operating-margin momentum.

Profitability Analysis

The reported annualized ROE is 12.5%, placing MTI within the 10-15% range generally regarded as good. The DuPont decomposition is net profit margin of 9.3% multiplied by annualized asset turnover of 0.928x and financial leverage of 1.44x. The principal constraint on profitability is asset utilization rather than leverage, as the company operates with a conservatively financed balance sheet. The 9.3% net margin is also in the good range, though it remains below the 10% level generally associated with excellent profitability. Gross margin declined to 73.1% from approximately 74.5% in the prior-year period, a 140bp decline. Operating margin contracted to 9.8% from approximately 10.5%, a 70bp decline. SG&A rose 3.3%, slower than revenue growth of 4.4%, indicating that the operating-margin deterioration did not arise from broad SG&A deleveraging. Rather, gross-profit pressure was the main operating issue. Ordinary income outperformed operating income because equity-method income increased to ¥0.55bn from ¥0.06bn in the prior-year period. This affiliate-income uplift is meaningful relative to operating income and should be distinguished from recurring consolidated operating earnings. The 5-factor DuPont profile is favorable from a financing perspective: the tax burden was 0.819 and the interest burden was 1.169, reflecting net non-operating income and very low interest costs. Interest expense was only ¥0.14bn, and interest coverage was 162.6x. Under JGAAP, goodwill is amortized; however, goodwill of ¥0.36bn is only 1.5% of equity and is not large enough to be a material cross-standard profitability distortion.

Growth Assessment

Revenue growth was driven by Healthcare, School DX, and Other businesses, while the Content business contracted. Content revenue declined 4.6% year on year to ¥121.68bn, making it the principal headwind because it remains the largest business by revenue and segment profit contribution. Content segment profit nevertheless increased 10.6% to ¥3.36bn, lifting its segment margin to 27.6% from 23.8%. Healthcare revenue rose 19.3% to ¥58.23bn, demonstrating the strongest absolute growth contribution among the reporting segments. Healthcare moved from a ¥0.76bn segment profit to a ¥5.66bn segment loss, however, implying that growth is presently being purchased at a substantial cost and requires close monitoring. School DX revenue expanded 29.9% to ¥17.64bn and segment profit increased 66.9% to ¥6.41bn, raising its segment margin to 36.3% from 28.3%. Other revenue grew 6.3% to ¥35.23bn and segment profit was broadly stable at ¥8.26bn. The Content business is the core business by segment operating-income contribution, while School DX currently exhibits the strongest combination of revenue growth and margin improvement. Revenue recognized over time increased 66.0% to ¥0.89bn, although it still represents only 3.8% of external revenue; the group therefore remains predominantly dependent on point-in-time revenue. Full-year sales guidance of ¥31.50bn implies a Q3 sales progress rate of 73.9%, close to the standard 75% level. Operating-income progress of 84.2% is 9.2 percentage points above the standard pace, while ordinary-income progress of 90.9% and owner-attributable-profit progress of 81.2% are more than 10 percentage points ahead of the standard pace. This guidance profile indicates a planned earnings deceleration in Q4, particularly below ordinary income, and suggests that Q3 affiliate-income strength is not assumed to recur at the same level. Management's revised forecast should therefore be assessed against the durability of segment profitability, especially the turnaround path for Healthcare.

Financial Health

Financial health is strong. Current assets of ¥22.05bn exceeded current liabilities of ¥7.87bn by ¥14.17bn, producing a current ratio and quick ratio of 280.0%. Cash and deposits of ¥16.12bn alone were more than twice current liabilities, providing substantial near-term liquidity. Contract liabilities totaled ¥3.39bn, which provides a meaningful source of operating funding and reduces near-term liquidity pressure. Total liabilities represented 30.7% of total assets, while total equity was ¥23.19bn. The reported debt-to-equity ratio was 0.44x, below the 1.0x conservative benchmark, and debt/capital was only 1.7%. Interest coverage of 162.6x confirms that financing costs are immaterial relative to operating earnings. The current portion of long-term loans was ¥0.74bn and long-term loans were ¥0.40bn, both readily covered by cash balances and working capital. Long-term loans decreased 57.8% year on year from ¥0.96bn to ¥0.40bn, further reducing balance-sheet financial risk. Net defined-benefit liability was ¥1.94bn, representing the largest identified non-debt long-term obligation and a relevant liability for funding and actuarial assumptions. Deferred tax assets were ¥2.21bn, equivalent to 6.6% of total assets, and their realization remains linked to sustained taxable profitability. Goodwill increased from ¥0.06bn to ¥0.36bn, but goodwill/equity of 1.5% and goodwill/assets of 1.1% indicate limited balance-sheet dependence on acquisition values. No segment impairment was recorded during the period.

Notable B/S Changes

Goodwill: +¥0.29bn (+477.1%) to ¥0.36bn - likely reflects an acquisition or business-combination effect; absolute impairment exposure remains low at 1.5% of equity. Property, plant and equipment: +¥0.23bn (+104.3%) to ¥0.45bn - indicates increased tangible investment, although PPE remains only 1.3% of total assets. Long-term loans: -¥0.55bn (-57.8%) to ¥0.40bn - deleveraging further strengthens the already conservative capital structure. Investment securities: +¥0.65bn (+13.8%) to ¥5.34bn - securities now account for 16.0% of assets, increasing exposure to investee performance and market valuation changes. Cash and deposits: -¥1.70bn (-9.5%) to ¥16.12bn - liquidity remains substantial despite the lower cash balance. Contract liabilities: +¥0.66bn (+24.4%) to ¥3.39bn - larger customer prepayments support operating funding and indicate growth in advance-billed or advance-collected arrangements.

Cash Flow Quality

The cash balance of ¥16.12bn provides a substantial internal funding buffer relative to the ¥2.18bn of Q3 cumulative profit attributable to owners. Contract liabilities increased to ¥3.39bn from ¥2.73bn in the prior-year period, supporting operating funding through customer prepayments and indicating that cash collection can precede revenue recognition for part of the business. Receivables were stable at ¥4.09bn year on year despite revenue growth, which is constructive for working-capital discipline. Accounts payable declined to ¥0.91bn from ¥1.02bn, meaning the stable receivable balance was not accompanied by an apparent extension of supplier payment terms. Cash and deposits declined by ¥1.70bn year on year, while investment securities increased by ¥0.65bn and software increased by ¥0.29bn. The increase in software and intangible assets is consistent with continued product and platform investment, particularly relevant to IT, healthcare, and education services. The balance-sheet evidence points to ample capacity to fund operations, product investment, and shareholder distributions without reliance on incremental financial debt.

Dividend Sustainability

The interim dividend was ¥10.00 per share, and the indicated full-year dividend is ¥20.00 per share. Based on full-year forecast EPS of ¥48.25, the implied dividend payout ratio is approximately 41.5%. This is below the 60% sustainability benchmark and leaves a material portion of earnings available for investment, balance-sheet resilience, or additional capital returns. The calculated payout ratio based on the interim payment and reported cumulative earnings was 27.8%. The company also has a large cash balance of ¥16.12bn and limited debt/capital of 1.7%, strengthening dividend capacity. Retained earnings increased to ¥9.74bn from ¥8.71bn year on year, reflecting continued accumulation of distributable capital. Dividend sustainability is therefore supported by profitability, liquidity, and low leverage. The principal determinant of future dividend growth will be the durability of operating profit in the core Content business and the timing of Healthcare profitability normalization.

Risk Assessment

Business risks include Content business revenue declined 4.6% year on year to ¥121.68bn. As the largest business by sales and segment profit, continued contraction could constrain group growth even if its current segment margin remains strong., Healthcare revenue expanded 19.3%, but segment performance deteriorated from a ¥0.76bn profit to a ¥5.66bn loss. The scale of this loss creates material execution risk around customer acquisition, development spending, monetization, and the timeline to profitability., The group operates in IT, digital healthcare, and education technology markets, where technology obsolescence, cybersecurity incidents, data-privacy regulation, and competition for skilled personnel can affect service continuity, customer retention, and development costs., School DX delivered strong 29.9% revenue growth and a 36.3% segment margin, but public-sector and education-related demand can be affected by procurement cycles, budget timing, and policy changes., Ordinary-income growth was assisted by ¥0.55bn of equity-method earnings from affiliates. Affiliate performance, investment valuation, and strategic-partner execution may cause earnings volatility outside consolidated operating control..

Financial risks include Net defined-benefit liability of ¥1.94bn exposes the group to interest-rate, asset-return, and actuarial-assumption changes., Deferred tax assets of ¥2.21bn are meaningful relative to total assets and depend on the group's ability to generate future taxable income., Investment securities totaled ¥5.34bn, or 16.0% of total assets. Valuation movements and investee performance may affect other comprehensive income and, in certain cases, earnings., Goodwill rose 477.1% to ¥0.36bn. The absolute exposure is limited, but the increase should be monitored for integration performance and future impairment indicators..

Key concerns include Operating income declined 3.0% despite 4.4% revenue growth, with gross margin down 140bp and operating margin down 70bp., The forecast implies Q4 slowing from the Q3 cumulative run rate: sales progress is normal at 73.9%, but ordinary-income and net-income progress are 90.9% and 81.2%, respectively., The healthcare loss is the most material segment-level issue because it offsets profit expansion in Content and School DX., The large gap between ordinary-income growth and operating-income decline increases the importance of separating affiliate-income benefits from underlying consolidated operating performance..

Investment Implications

Key takeaways include Revenue growth of 4.4% was resilient, supported by Healthcare, School DX, and Other businesses., Core operating profitability softened, with operating income down 3.0% and operating margin declining to 9.8%., School DX is the strongest growth-and-margin contributor, while Healthcare has become the key profitability drag., Content remains the core earnings business, with segment profit up 10.6% despite a 4.6% decline in revenue., Ordinary income and net income benefited from stronger equity-method earnings and a low effective tax rate., Liquidity and solvency are strong, with ¥16.12bn in cash, a 280.0% current ratio, 1.7% debt/capital, and 162.6x interest coverage., The implied full-year dividend payout ratio of approximately 41.5% appears conservatively funded by forecast earnings and the balance sheet..

Metrics to watch include Content revenue trend and segment margin, Healthcare segment loss, revenue growth, and path to break-even, School DX revenue growth and segment-margin durability, Group gross margin and operating margin, Equity-method earnings contribution to ordinary income, Q4 delivery versus full-year operating-income guidance of ¥2.70bn, Investment-securities valuation and deferred-tax-asset realization, Software and goodwill additions relative to operating-profit growth.

Regarding relative positioning, MTI combines a high gross-margin digital-services model with a very conservative balance sheet and annualized ROE of 12.5%, which is a favorable financial profile for an IT-services-oriented company. Relative operating performance is mixed: the 9.8% operating margin remains in the good benchmark range, but margin compression and the Healthcare loss weaken the quality of top-line growth. The limited goodwill exposure and low debt distinguish the company from more acquisition- or leverage-dependent peers, while the concentration of core earnings in Content and the dependence of recent ordinary-income growth on affiliate earnings remain important differentiators.